Vivasure wins FDA IDE, receives €30M from Haemonetics
Vivasure Medical announced that it received FDA investigational device exemption (IDE) to advance a clinical study of its PerQseal device.
Source: massdevice.com
Stay updated with breaking news from Stew Strong. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Vivasure Medical announced that it received FDA investigational device exemption (IDE) to advance a clinical study of its PerQseal device.
/PRNewswire/ -- Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative medical solutions to drive better...